Evidence map›Paper›PMID 35807211›Full record

ArticleMolecules (Basel, Switzerland)2022

Pathway Dependence of the Formation and Development of Prefibrillar Aggregates in Insulin B Chain.

Yuki Yoshikawa, Keisuke Yuzu, Naoki Yamamoto, Ken Morishima, Rintaro Inoue, Masaaki Sugiyama, Tetsushi Iwasaki, Masatomo So, Yuji Goto, Atsuo Tamura and 1 more

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Yuki YoshikawaGraduate School of Science, Kobe University, 1-1 Rokkodai, Nada, Kobe 657-8501, Hyogo, Japan.
Keisuke YuzuGraduate School of Science, Kobe University, 1-1 Rokkodai, Nada, Kobe 657-8501, Hyogo, Japan.
Naoki YamamotoDivision of Biophysics, Physiology, School of Medicine, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke 329-0498, Tochigi, Japan.
Ken MorishimaInstitute for Integrated Radiation and Nuclear Science, Kyoto University, 2 Asashiro-Nishi, Kumatori, Sennan-gun 590-0494, Osaka, Japan.ORCID 0000-0003-1091-3850
Rintaro InoueInstitute for Integrated Radiation and Nuclear Science, Kyoto University, 2 Asashiro-Nishi, Kumatori, Sennan-gun 590-0494, Osaka, Japan.
Masaaki SugiyamaInstitute for Integrated Radiation and Nuclear Science, Kyoto University, 2 Asashiro-Nishi, Kumatori, Sennan-gun 590-0494, Osaka, Japan.
Tetsushi IwasakiGraduate School of Science, Kobe University, 1-1 Rokkodai, Nada, Kobe 657-8501, Hyogo, Japan.
Masatomo SoInstitute for Protein Research, Osaka University, 3-2 Yamadaoka, Suita 565-0871, Osaka, Japan.ORCID 0000-0002-4815-4995
Yuji GotoGlobal Center for Medical Engineering and Informatics, Osaka University, 2-1 Yamadaoka, Suita 565-0871, Osaka, Japan.
Atsuo TamuraGraduate School of Science, Kobe University, 1-1 Rokkodai, Nada, Kobe 657-8501, Hyogo, Japan.
Eri ChataniGraduate School of Science, Kobe University, 1-1 Rokkodai, Nada, Kobe 657-8501, Hyogo, Japan.
Kobe University · JPKyoto University · JPThe University of Osaka · JPJichi Medical University · JP

Funding

Japan Society for the Promotion of Science JP17H06352Japan Society for the Promotion of Science JP18H03681Japan Society for the Promotion of Science JP18H05229Japan Society for the Promotion of Science JP18H05534Japan Society for the Promotion of Science JP19K16088Japan Society for the Promotion of Science JP19KK0071Japan Society for the Promotion of Science JP20H03224Japan Society for the Promotion of Science JP20K06579Japan Society for the Promotion of Science JP20K21396Japan Society for the Promotion of Science JP21K15051
6 · The paper itself

Abstract

Amyloid fibrils have been an important subject as they are involved in the development of many amyloidoses and neurodegenerative diseases. The formation of amyloid fibrils is typically initiated by nucleation, whereas its exact mechanisms are largely unknown. With this situation, we have previously identified prefibrillar aggregates in the formation of insulin B chain amyloid fibrils, which have provided an insight into the mechanisms of protein assembly involved in nucleation. Here, we have investigated the formation of insulin B chain amyloid fibrils under different pH conditions to better understand amyloid nucleation mediated by prefibrillar aggregates. The B chain showed strong propensity to form amyloid fibrils over a wide pH range, and prefibrillar aggregates were formed under all examined conditions. In particular, different structures of amyloid fibrils were found at pH 5.2 and pH 8.7, making it possible to compare different pathways. Detailed investigations at pH 5.2 in comparison with those at pH 8.7 have suggested that the evolution of protofibril-like aggregates is a common mechanism. In addition, different processes of evolution of the prefibrillar aggregates have also been identified, suggesting that the nucleation processes diversify depending on the polymorphism of amyloid fibrils.

Indexed as

AmyloidInsulinAmyloidogenic ProteinsProtein BindingAmyloidAmyloidogenic ProteinsInsulinamyloidinsulin B chainnucleationprefibrillar aggregatesprotofibrils

Identifiers

PMID35807211
PMCPMC9268647
OpenAlexW4283207086

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.